The Health Innovation Roundup, sponsored by Health Cities, is written and published weekly by Taproot Edmonton to bring you the latest news and events in research, technology, companies and people changing health for the better in Edmonton. Sign up to get the full edition delivered directly to your inbox. Use the code HEALTHCITY & you’ll get 10% off the first year. Here are some highlights from this week’s Health Innovation Roundup: Headlines University of Alberta researchers announced a new discovery related to how breast cancer spreads in the body. The study identified a protein, known as BAD, with the ability to activate a cell death process called apoptosis. A new U of A study has found that patients with breast cancer who were physically fit were more likely to complete their chemotherapy treatments. “This study was the first to look at how muscular strength and aerobic fitness may influence chemotherapy treatment adherence,” said study co-lead Dr. Kerry Courneya. Translational Research in Oncology (TRIO) announced the enrollment of the first patient in its breast cancer trial, a Phase 3 randomized global clinical trial of adjuvant endocrine therapy. TRIO is expecting to enroll 4,000 patients across 20 countries. AI/ML Innovations said that its Edmonton-based subsidiary Health Gauge is working with leading organizations like BioAlberta, Health Cities, and the Alberta Machine Intelligence Institute (Amii) to advance the development of “a transformative, wearable health monitoring solution that is poised to make its mark on the digital healthcare world.” Alberta Innovates and the Edmonton Regional Innovation Network have partnered with Connection Silicon Valley (CSV) to launch the Access to Global Capital program. This accelerator program will help Edmonton startups navigate the “early-stage ecosystem towards their first institutional fundraise.” Applications are open until Sept. 15. The deadline for Accelerating Innovations into CarE (AICE) – Concepts is Sept. 1. The Alberta Innovates program aims to advance early-stage health research. Campus Alberta Neuroscience is launching a seven-week cohort program to help commercialize neuroscience research. The application deadline is Sept. 24. The deadline for the University Hospital Foundation‘s medical research competition is Sept. 23. The competition provides seed grants to scientists from the University of Alberta’s faculty of medicine and dentistry. The Royal Alexandra Hospital Foundation has received a “significant donation” from MHCare Medical. The donation will be used to buy new equipment to enhance the hospital’s respiratory care unit. The U of A has recently appointed Dr. Spencer Gibson as the new Dianne and Irving Kipnes Chair in Lymphatic Disorders. Gibson, who served as the director of the CancerCare Manitoba Research Institute said the long-term goal is to be “an internationally recognized centre for this type of research.” Inventures 2021 announced the names of its startup pitch finalists and alternates. Edmonton-based Gru Organics and Umay Care are on the list. Events Sept. 7, 12pm: The Challenges to Make a Vaccine Against Malaria Sept. 13-14 : The Biome Summit 2021 – Edmonton Sept. 15: A discussion on Artificial Intelligence in Health Sept. 16, 9am: EDI, Two-Eyed Seeing and Strengths-based Indigenous Patient-Oriented Research Sept. 22, 12pm: Achieving Equitable Access to High Quality Obstetric, Surgical and Anesthesia Care Sept. 22-24: Inventures 2021 Oct. 4, 11am: Stroke Rehabilitation Challenge Forum Oct. 5 & 6: Canada’s Medtech Conference 2021 Oct. 25-27: Alberta Cancer Research Conference 2021 Oct. 26-27: Canadian Computational Neuroscience Symposium Nov. 3 & 4: i4 2021 Virtual Conference Dec. 2-5: University Hospital Foundation’s Festival of Trees Dec. 10-11: Reimagining Public Spaces and Built Environments in the Post-pandemic World Have a suggestion for a future edition? Send it to hello@taprootedmonton.ca for consideration. Become a “Roundup Cultivator” and sponsor Taproot Edmonton to help them chronicle health innovation in Edmonton. Learn more